Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Company Overview - Repligen Corp positions itself as an innovation leader in the bioprocessing industry, focusing on supporting biopharmaceutical and CDMO customers with a differentiated portfolio of hardware and consumables [3][4] - The company emphasizes its commitment to innovation, claiming that approximately 80% of its portfolio operates in market segments without direct competitors, thereby creating new market opportunities [4] Leadership and Presentation - The session is hosted by Mike Ryskin from the Bank of America Life Science Tools and Diagnostics team, featuring Jason Garland (CFO) and Olivier Loeillot (CEO) of Repligen Corp [1][2] - Olivier Loeillot expresses gratitude for the attendance and aims to provide a concise overview of the company during the presentation [2]